215 related articles for article (PubMed ID: 30097188)
1. Major coronary evaginations following implantation of bioresorbable vascular scaffolds - Clinical and OCT characteristics.
Blachutzik F; Achenbach S; Marwan M; Röther J; Tröbs M; Schneider R; Nef H; Weissner M; Schlundt C
Cardiovasc Revasc Med; 2019 Jun; 20(6):485-491. PubMed ID: 30097188
[TBL] [Abstract][Full Text] [Related]
2. OCT-assessment of scaffold resorption: Analysis of strut intensity by a new resorption index for poly-l-lactic acid bioresorbable vascular scaffolds.
Blachutzik F; Achenbach S; Marwan M; Tröbs M; Boeder N; Doerr O; Weissner M; Bauer T; Nef H; Hamm C; Schlundt C
Catheter Cardiovasc Interv; 2019 Dec; 94(7):928-935. PubMed ID: 30945432
[TBL] [Abstract][Full Text] [Related]
3. Scaffold and edge vascular response following implantation of everolimus-eluting bioresorbable vascular scaffold: a 3-year serial optical coherence tomography study.
Zhang YJ; Iqbal J; Nakatani S; Bourantas CV; Campos CM; Ishibashi Y; Cho YK; Veldhof S; Wang J; Onuma Y; Garcia-Garcia HM; Dudek D; van Geuns RJ; Serruys PW;
JACC Cardiovasc Interv; 2014 Dec; 7(12):1361-9. PubMed ID: 25457053
[TBL] [Abstract][Full Text] [Related]
4. Incidence and imaging outcomes of acute scaffold disruption and late structural discontinuity after implantation of the absorb Everolimus-Eluting fully bioresorbable vascular scaffold: optical coherence tomography assessment in the ABSORB cohort B Trial (A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).
Onuma Y; Serruys PW; Muramatsu T; Nakatani S; van Geuns RJ; de Bruyne B; Dudek D; Christiansen E; Smits PC; Chevalier B; McClean D; Koolen J; Windecker S; Whitbourn R; Meredith I; Garcia-Garcia HM; Veldhof S; Rapoza R; Ormiston JA
JACC Cardiovasc Interv; 2014 Dec; 7(12):1400-11. PubMed ID: 25523532
[TBL] [Abstract][Full Text] [Related]
5. Effect of Plaque Composition, Morphology, and Burden on DESolve Novolimus-Eluting Bioresorbable Vascular Scaffold Expansion and Eccentricity - An Optical Coherence Tomography Analysis.
Boeder NF; Dörr O; Bauer T; Elsässer A; Möllmann H; Achenbach S; Hamm CW; Nef HM
Cardiovasc Revasc Med; 2019 Jun; 20(6):480-484. PubMed ID: 30638889
[TBL] [Abstract][Full Text] [Related]
6. Predictors of acute scaffold recoil after implantation of the everolimus-eluting bioresorbable scaffold: an optical coherence tomography assessment in native coronary arteries.
Sato T; Jose J; El-Mawardy M; Sulimov DS; Tölg R; Richardt G; Abdel-Wahab M
Int J Cardiovasc Imaging; 2017 Feb; 33(2):145-152. PubMed ID: 27761749
[TBL] [Abstract][Full Text] [Related]
7. Routine use of optical coherence tomography in bioresorbable vascular scaffold implantation: insights on technique optimization and long-term outcomes.
Abdelaziz HK; Abuomara HZ; Ali MH; Eichhofer J; Patel B; Saad M
Coron Artery Dis; 2019 Jun; 30(4):263-269. PubMed ID: 30883433
[TBL] [Abstract][Full Text] [Related]
8. Impact of strut thickness on acute mechanical performance: A comparison study using optical coherence tomography between DESolve 150 and DESolve 100.
Boeder NF; Dörr O; Bauer T; Mattesini A; Elsässer A; Liebetrau C; Achenbach S; Hamm CW; Nef HM
Int J Cardiol; 2017 Nov; 246():74-79. PubMed ID: 28579164
[TBL] [Abstract][Full Text] [Related]
9. Effect of non-compliant balloon postdilatation on magnesium-based bioresorbable vascular scaffolds.
Blachutzik F; Achenbach S; Tröbs M; Marwan M; Weissner M; Nef H; Schlundt C
Catheter Cardiovasc Interv; 2019 Feb; 93(2):202-207. PubMed ID: 30196573
[TBL] [Abstract][Full Text] [Related]
10. First in human evaluation of the vascular biocompatibility and biomechanical performance of a novel ultra high molecular weight amorphous PLLA bioresorbable scaffold in the absence of anti-proliferative drugs: Two-year imaging results in humans.
Moncada M; Delgado JA; Colombo A; Gasior P; Ramzipoor K; Estrada A; Lee C; Dokko D; Granada JF
Catheter Cardiovasc Interv; 2018 Sep; 92(3):E246-E253. PubMed ID: 29243353
[TBL] [Abstract][Full Text] [Related]
11. Five-year clinical and functional multislice computed tomography angiographic results after coronary implantation of the fully resorbable polymeric everolimus-eluting scaffold in patients with de novo coronary artery disease: the ABSORB cohort A trial.
Onuma Y; Dudek D; Thuesen L; Webster M; Nieman K; Garcia-Garcia HM; Ormiston JA; Serruys PW
JACC Cardiovasc Interv; 2013 Oct; 6(10):999-1009. PubMed ID: 24156961
[TBL] [Abstract][Full Text] [Related]
12. First serial assessment at 6 months and 2 years of the second generation of absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study.
Ormiston JA; Serruys PW; Onuma Y; van Geuns RJ; de Bruyne B; Dudek D; Thuesen L; Smits PC; Chevalier B; McClean D; Koolen J; Windecker S; Whitbourn R; Meredith I; Dorange C; Veldhof S; Hebert KM; Rapoza R; Garcia-Garcia HM
Circ Cardiovasc Interv; 2012 Oct; 5(5):620-32. PubMed ID: 23048057
[TBL] [Abstract][Full Text] [Related]
13. ABSORB biodegradable stents versus second-generation metal stents: a comparison study of 100 complex lesions treated under OCT guidance.
Mattesini A; Secco GG; Dall'Ara G; Ghione M; Rama-Merchan JC; Lupi A; Viceconte N; Lindsay AC; De Silva R; Foin N; Naganuma T; Valente S; Colombo A; Di Mario C
JACC Cardiovasc Interv; 2014 Jul; 7(7):741-50. PubMed ID: 25060016
[TBL] [Abstract][Full Text] [Related]
14. Randomized Comparison of Absorb Bioresorbable Vascular Scaffold and Mirage Microfiber Sirolimus-Eluting Scaffold Using Multimodality Imaging.
Tenekecioglu E; Serruys PW; Onuma Y; Costa R; Chamié D; Sotomi Y; Yu TB; Abizaid A; Liew HB; Santoso T
JACC Cardiovasc Interv; 2017 Jun; 10(11):1115-1130. PubMed ID: 28527768
[TBL] [Abstract][Full Text] [Related]
15. Overlapping implantation of bioresorbable novolimus-eluting scaffolds: an observational optical coherence tomography study.
Blachutzik F; Boeder N; Wiebe J; Mattesini A; Dörr O; Most A; Bauer T; Tröbs M; Röther J; Schlundt C; Achenbach S; Hamm C; Nef H
Heart Vessels; 2017 Jul; 32(7):781-789. PubMed ID: 28004176
[TBL] [Abstract][Full Text] [Related]
16. Effect of Post-Dilatation Following Primary PCI With Everolimus-Eluting Bioresorbable Scaffold Versus Everolimus-Eluting Metallic Stent Implantation: An Angiographic and Optical Coherence Tomography TROFI II Substudy.
Yamaji K; Brugaletta S; Sabaté M; Iñiguez A; Jensen LO; Cequier A; Hofma SH; Christiansen EH; Suttorp M; van Es GA; Sotomi Y; Onuma Y; Serruys PW; Windecker S; Räber L
JACC Cardiovasc Interv; 2017 Sep; 10(18):1867-1877. PubMed ID: 28935079
[TBL] [Abstract][Full Text] [Related]
17. Serial invasive imaging follow-up of the first clinical experience with the Magmaris magnesium bioresorbable scaffold.
Tovar Forero MN; van Zandvoort L; Masdjedi K; Diletti R; Wilschut J; de Jaegere PP; Zijlstra F; Van Mieghem NM; Daemen J
Catheter Cardiovasc Interv; 2020 Feb; 95(2):226-231. PubMed ID: 31033171
[TBL] [Abstract][Full Text] [Related]
18. Head-to-head comparison of the neointimal response between metallic and bioresorbable everolimus-eluting scaffolds using optical coherence tomography.
Gomez-Lara J; Brugaletta S; Farooq V; Onuma Y; Diletti R; Windecker S; Thuesen L; McClean D; Koolen J; Whitbourn R; Dudek D; Smits PC; Chevalier B; Regar E; Veldhof S; Rapoza R; Ormiston JA; Garcia-Garcia HM; Serruys PW
JACC Cardiovasc Interv; 2011 Dec; 4(12):1271-80. PubMed ID: 22192368
[TBL] [Abstract][Full Text] [Related]
19. Post-dilatation after implantation of bioresorbable everolimus- and novolimus-eluting scaffolds: an observational optical coherence tomography study of acute mechanical effects.
Blachutzik F; Boeder N; Wiebe J; Mattesini A; Dörr O; Most A; Bauer T; Röther J; Tröbs M; Schlundt C; Achenbach S; Hamm CW; Nef HM
Clin Res Cardiol; 2017 Apr; 106(4):271-279. PubMed ID: 27757522
[TBL] [Abstract][Full Text] [Related]
20. Coronary evaginations and peri-scaffold aneurysms following implantation of bioresorbable scaffolds: incidence, outcome, and optical coherence tomography analysis of possible mechanisms.
Gori T; Jansen T; Weissner M; Foin N; Wenzel P; Schulz E; Cook S; Münzel T
Eur Heart J; 2016 Jul; 37(26):2040-9. PubMed ID: 26543048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]